Analyses of a Subset of Patients with Primary Immunodeficiency Diseases (PIDD) Who Switched Modes of Administration of Immunoglobulin (Ig) Therapy during Three Consecutive Studies

Conclusions Long-term evaluation of the same patient cohort over three consecutive studies demonstrated that IGHy, compared to the other modes of Ig therapy patients received prior to initiating IGHy provided similar efficacy, and safety and tolerability profiles.

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2017-02, Vol.139 (2), p.AB18-AB18
Main Authors: Wasserman, Richard L., MD, PhD, FAAAAI, Gupta, Sudhir, MD, PhD, MACP, Stein, Mark R., MD, FAAAAI, Melamed, Isaac Reuven, MD, Puck, Jennifer M., MD, Engl, Werner, PhD, Leibl, Heinz, PhD, Rabbat, Christopher J., PhD, Yel, Leman, MD, FAAAAI
Format: Article
Language:English
Subjects:
Allergy and Immunology
Infections
Patients
Studies
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Conclusions Long-term evaluation of the same patient cohort over three consecutive studies demonstrated that IGHy, compared to the other modes of Ig therapy patients received prior to initiating IGHy provided similar efficacy, and safety and tolerability profiles.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2016.12.013